Home

Picture2

Empowering researchers to accelerate science for COVID-19

Down Arrow

  • Create your study
  • Deploy your unique data collection app
  • Manage your data


Empowering the researchers to accelerate science for COVID-19

About us

MORE
Gain visibility for your COVID-19 study with EpidemiXs Studies.

Visibility for studies

We disseminate and share studies on SARS-CoV-2 and COVID-19, helping researchers to gain exposure with a wide community of citizens, researchers & institutions

Participate and collaborate with COVID-19 studies, with EpidemiXs Studies.

Participate & collaborate

Citizens can participate by contributing their data to ongoing studies, while researchers can collaborate to expand their dataset

Find funders for your COVID-19 study with EpidemiXs Studies.

Find funders

Researchers can expand the reach of crowdfunding campaigns for their studies and get access to other channels of funding

Deploy your COVID-19 study with EpidemiXs Studies.

Deploy your study

Deploy your study through the EpidemiXs Studies platform to quickly create a unique data collection tool for your study and accelerate your research

What do we want?

Give visibility to your studies

Allow you to participate and collaborate with active studies

Promote your crowdfunding campaign

Create an Open Data Hub where you can download data to accelerate your research

DO YOU WANT TO KNOW MORE ABOUT US AND WHAT WE DO? CLICK HERE!

Or…

ARE YOU ALREADY CONVINCED AND WANT TO KNOW HOW YOU CAN COLLABORATE?
EpidemiXs Studies

The Latest Studies

Collaborate
Crowdfunding
Participate
Captura

Millennium COVID-19 Care Center, Addis Ababa, Ethiopia  

The COVID-19 Pandemic in Ethiopia

Epidemiological

PA prospective observational cohort study designed to understand the characteristics and outcomes of the profile of Hospitalized African COVID-19 patients.

Red Blood Cells 2

National Research Center for Hematology et. al., Russia  

CHRONOS19: Hematologic diseases and COVID-19

Clinical Trial

A Russian study to determine the severity and lethality of COVID-19 infection in patients with hematologic diseases.

Agil

CAP Bordeta-Magòria, Spain  

Impact of the Lockdown due to COVID-19 on Frail Older Adults

Fragility Other Studies

This study, the first one of the +AGIL-COVID19 program, assesses the effect of the lockdown due to the COVID-19 on physical activity levels and emotional wellbeing on frail older adults.

Institut Català de la Salut, Spain  

E-speranza-COVID19 Project

Clinical Trial Pharmacology

This study aims to demonstrate efficacy of Montelukast for patients with persistent COVID-19 to help them improve their quality of life.

Influenza Vaccine Compr

Consorci Sanitari de Terrassa, Spain  

Influenza Vaccination, ACEI and ARB in the Evolution of COVID-19

Clinical Trial Pharmacology

A study to determine if influenza vaccination or ACEI or ARB medication has effects on COVID-19.

React 1 Principal

Imperial College London et al., United Kingdom  

REACT-1: Virus Prevalence in England

Epidemiological

How the COVID-19 pandemic is progressing across England? This study will help to estimate COVID-19 virus infection prevalence by a REal-time Assesment of Community Transmission (REACT).

SEE ALL

Categories

Collaborate with us

Citizens

Discover ongoing studies and participate to make a difference in the fight against COVID-19
Explore

Researchers

Collaborate with other research studies or create, deploy and manage your own study quickly and easily through the EpidemiXs Studies platform
Explore

Funders

Fund research studies featured in our repository to support their research goals and accelerate science and potential breakthroughs against COVID-19
Explore